[Clinical study of the ocular effects of a new anti-inflammatory derivative of pyrazolidine (G-27 202 or tanderil)].
D000893:Anti-Inflammatory Agents; D035843:Biomedical Research; D005123:Eye; D006257:Head; D009885:Ophthalmology / Q000628:therapy*; D010113:Oxyphenbutazone; D010653:Phenylbutazone / Q000031:analogs & derivatives
D000893:Anti-Inflammatory Agents; D010653:Phenylbutazone; D010113:Oxyphenbutazone
OPHTHALMOLOGY/therapy; PHENYLBUTAZONE/related compounds